CNBC March 5, 2025
Key Points
– Novo Nordisk will offer its weight loss drug Wegovy for less than half of its usual price per month through a new direct-to-consumer online pharmacy.
– The cash-pay offering is available to millions of patients without insurance coverage for the blockbuster injection, such as those with Medicare.
– The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the weekly drug.
Novo Nordisk on Wednesday said it will offer its weight loss drug Wegovy for less than half of its usual price per month through a new direct-to-consumer online pharmacy.
The cash-pay offering is available to millions of patients without insurance coverage for the blockbuster injection. It aims to make Wegovy...
Today's Sponsors
Today's Sponsor